Skip to main content
OpenTrials
Completed

NCT Number: NCT04918160

Evaluation of the Sanitary Safety of a Healthcare Professional Conference Held 9-11 June 2021 in Paris

The COVID-SRLF study will evaluate the sanitary safety of the French Intensive Care Society (FICS) annual meeting held in Paris Congress Center from June 9th to June 11th 2021 in the Coronavirus Disease 2019 (COVID-2019) pandemic situation. The primary objective is to determine the proportion of attendees with a positive antigenic COVID-19 screening test at day 7 (+/- 1) of their participation to the meeting. This rate will be compared to a cohort of health care professionals (medical doctors and paramedical professionals) from the same hospital ward as the attendees but who did not attend the meeting (stratified on centers, gender, age (< and >= 40 years, vaccination status (0, 1 or 2 doses) and socio-professional status (medical doctor, nurse, nurse assistant).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre des Congres

Paris, 75017, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthcare professional healthy volunteer
  • Absence of COVID-19 symptoms in the 2 weeks prior to inclusion
  • Not being a COVID-19 contact case in the 2 weeks prior to inclusion
  • Participation to at least one day of the FICS annual meeting (June 9-11 2021)

Exclusion criteria

  • Non-healthcare professional (exhibitors, congress center employees)
  • Refusal to participate to the study
  • Person under legal protection
  • Absence of social security affiliation

Treatment and study plan

Exposure to the FICS annual meeting (June 9-11 2021, Paris Congress Center)

Other

The study will compare COVID-19 screening nasal antigenic self-test (Boiron Auto Test Covid Nasal) positivity at D7 and COVID-19 symptoms in the 21 days between participants to the FICS annual meeting held in June 9-11 2021 in the Paris Congress Center (conference attendees / exposed) and healthcare professionals who did not attend the meeting (controls / not exposed).

Primary outcomes

  1. Conference attendees COVID-19 prevalence at D7

    Time frame: Day 7 of the last day of the meeting (June 18th, 2021)

    Proportion of conference attendees with a positive COVID-19 autotest at day 7 of the last day of the meeting (June 18th, 2021).

Secondary outcomes

  1. Controls COVID-19 prevalence at D7

    Time frame: Day 7 of the last day of the meeting (June 18th, 2021)

    Proportion of controls (healthcare professional not participating to the conference) with a positive COVID-19 autotest at day 7 of the last day of the meeting (June 18th, 2021).

  2. Proportion of conference attendees with COVID-19 symptoms at D21

    Time frame: Day 21 of the last day of the congress (July 2, 2021)

    Proportion of conference attendees reporting COVID-19 compatible symptoms until day 21 of the last day of the congress (July 2, 2021).

  3. Proportion of conference attendees with COVID-19-related medical consultation at D21

    Time frame: Day 21 of the last day of the congress (July 2, 2021)

    Proportion of conference attendees reporting COVID-19-related medical consultation until day 21 of the last day of the congress (July 2, 2021).

  4. Proportion of conference attendees with COVID-19-related emergency department visit at D21

    Time frame: Day 21 of the last day of the congress (July 2, 2021)

    Proportion of conference attendees reporting COVID-19-related emergency department visit until day 21 of the last day of the congress (July 2, 2021).

  5. Proportion of conference attendees with COVID-19-related hospitalisation at D21

    Time frame: Day 21 of the last day of the congress (July 2, 2021)

    Proportion of conference attendees reporting COVID-19-related hospitalisation until day 21 of the last day of the congress (July 2, 2021).

Sponsors and collaborators

Lead sponsor

French Society for Intensive Care

Other

Registry information

Official study title

Evaluation of the Sanitary Safety of the French Intensive Care Society Annual Meeting Held From June 9th to June 11th 2021 at the Paris Congress Centre

Acronym: COVID-FREE

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Jun 8, 2021
Registry last updated
Oct 21, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.